AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Update

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 10,400 shares, a decline of 25.2% from the May 15th total of 13,900 shares. Based on an average daily volume of 188,700 shares, the short-interest ratio is currently 0.1 days.

AXIM Biotechnologies Trading Down 1.5%

Shares of AXIM opened at $0.01 on Friday. The firm’s fifty day moving average price is $0.01. AXIM Biotechnologies has a 12-month low of $0.00 and a 12-month high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.